Concepedia

John C. Flickinger

JC

7

Publications

387

Citations

7

H-Index

2017

Active since

Affiliations

Thomas Jefferson University(Current)

Sidney Kimmel Cancer Center

John C. Flickinger is an author at Thomas Jefferson University specializing in neuroimmunology, autoimmunity, and immune regulation.

ORCID

Top concepts

Publications per year

2017–2022

7

Publications

7

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases

Michael S. Magee, Tara S. Abraham, Trevor R. Baybutt et al. · Cancer Immunology Research · 2018 · 136 citations · Full text

T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation

Brandon Kwong, Réjane Rua, Yuanyuan Gao et al. · Nature Immunology · 2017 · 111 citations · Full text

, , +10

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients

Adam E. Snook, Trevor R. Baybutt, Bo Xiang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 58 citations · Full text

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

John C. Flickinger, Jagmohan Singh, Robert D. Carlson et al. · Journal for ImmunoTherapy of Cancer · 2020 · 37 citations · Full text

T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C

John C. Flickinger, Jagmohan Singh, Yanki Yarman et al. · Frontiers in Immunology · 2022 · 17 citations · Full text

Rows per page

1–5 of 7